Group: Advisors

Chris D. Brown, PhD

Co-Founder & CTO, 908 Devices

William Cantley, PhD

Senior Scientist, CNS Biology, Alnylam Pharmaceuticals

Michael Cuccarese, PhD

Senior Director, Oncology and industrialized drug discovery, Recursion, Inc

Konstantinos Gkatzis, PhD

Expert in cardiac and neuronal drug development programs, safety assessment (KSILINK, Myrtil Biosciences)

Keith James, PhD

Retired. Former SVP Drug Discovery Insitro, Previous executive positions with Ferring Pharmaceuticals & Pfizer

Lincoln Muir

Retired. Former Director of Commercial, North America Agilent Technologies (ACEA Biosciences)

Jerrold R. Turner, MD, PhD

Professor of Pathology & Medicine, Harvard Medical School Physician-scientist

Vladislav Zarayskiy, PhD

Director of Automation & Screening Technologies, Monte Rosa Therapeutics